From December 1, 2022 to February 28, 2023, the company has repurchased 30,000 shares, representing 0.03% for CAD 0.03 million. With this, the company has completed the repurchase of 30,000 shares, representing 0.03% for CAD 0.03 million under the buyback announced on November 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 CAD | -5.41% | -12.50% | -15.66% |
1st Jan change | Capi. | |
---|---|---|
-15.66% | 48.54M | |
-.--% | 339M | |
+32.99% | 266M | |
+35.80% | 264M | |
+45.06% | 185M | |
+164.52% | 152M | |
-28.57% | 145M | |
-37.75% | 141M | |
+53.70% | 137M | |
-7.69% | 79.94M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.